Investigation of Potential Action on Behalf of Current Sinovac Biotech Ltd. Shareholders
Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac”) is a Chinese biopharmaceutical company that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Shares of Sinovac (SVA) have been halted on the Nasdaq since February 2019. Kessler Topaz is investigating potential claims on behalf of current Sinovac shareholders who are currently unable to trade their stock.
If you currently own shares of Sinovac (NASDAQ: SVA) and would like to learn more about our investigation, please fill out our online form or contact James Maro at (484) 270-1453; or via email at info@ktmc.com.